Suppr超能文献

16例淋巴浆细胞淋巴瘤/华氏巨球蛋白血症的临床特征

[Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia].

作者信息

Wang Ji-Jun, Jing Hong-Mei, Shen Hong-Wei, Xu Jiao-Sheng, Li Min, Gao Zi-Feng, Ke Xiao-Yan

机构信息

Department of Hematology, Peking University Third Hospital, Beijing 100191, China.

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1494-8.

Abstract

In order to investigate the clinical manifestations, diagnosis, therapy and prognosis of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM), 16 patients with LPL/WM were analyzed retrospectively. The results showed that the average age of 16 patients with LPL/WM was 65.1 years old, the most common syndromes were anemia and hyperviscosity syndrome, bone marrows were composed of small lymphocyte, admixed with variable numbers of plasma cells and plasmacytoid lymphocytes. And lymph node biopsy revealed that most cells expressed B-cell-associated antigen. Among the 16 cases, complete remission was 25%, overall response rate (ORR) was 81.3%, overall survival time was 6 to 108 months. 3 patients died and survival rate was 81.3 %. It is concluded that the clinical course of LPL/WM is typically indolent. These patients can acquire remission in clinic, but can not be cured, some of them can transform into patients with more malignant lymphoma.

摘要

为了探讨淋巴浆细胞淋巴瘤/华氏巨球蛋白血症(LPL/WM)的临床表现、诊断、治疗及预后,对16例LPL/WM患者进行回顾性分析。结果显示,16例LPL/WM患者的平均年龄为65.1岁,最常见的症状为贫血和高黏滞综合征,骨髓由小淋巴细胞组成,混有数量不等的浆细胞和浆细胞样淋巴细胞。淋巴结活检显示大多数细胞表达B细胞相关抗原。16例中,完全缓解率为25%,总缓解率(ORR)为81.3%,总生存时间为6至108个月。3例死亡,生存率为81.3%。结论是,LPL/WM的临床病程通常较为惰性。这些患者在临床上可获得缓解,但无法治愈,部分患者可转化为更具侵袭性的淋巴瘤患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验